Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Jun 8;3(3):581.
doi: 10.1002/jha2.429. eCollection 2022 Aug.

Into the limelight: TPA for critically ill Covid-19 patients

Affiliations
Editorial

Into the limelight: TPA for critically ill Covid-19 patients

Eslam Abbas et al. EJHaem. .
No abstract available

PubMed Disclaimer

References

    1. Zhang Z, Zhai Z, Liang L, Liu F, Yang Y, Wang C. Lower dosage of recombinant tissue‐type plasminogen activator (rt‐PA) in the treatment of acute pulmonary embolism: a systematic review and meta‐analysis. Thromb Res. 2014;133(3):357–63. - PubMed
    1. Konstantinides SV, Meyer G, Becattini C, Bueno H, Geersing G‐J, Harjola V‐P, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) The Task Force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). Eur Heart J. 2020;41(4):543–603. - PubMed
    1. Tisdale JE, Colucci RD, Ujhelyi MR, Kluger J, Fieldman A, Chow MSS. Evaluation and comparison of the adverse effects of streptokinase and alteplase. Pharmacother J Hum Pharmacol Drug Ther. 1992;12(6):440–4. - PubMed
    1. Schulman S, Kearon C, Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non‐surgical patients. J Thromb Haemost. 2005;3(4):692–4. - PubMed
    1. Roskell NS, Samuel M, Noack H, Monz BU. Major bleeding in patients with atrial fibrillation receiving vitamin K antagonists: a systematic review of randomized and observational studies. Europace 2013;15(6):787–97. - PMC - PubMed

Publication types